
Popular dried fruit pulled from shelves in 19 states
A recall of certain cases of Floria Dried Apricots is underway due to their packaging not disclosing the fruit contains sulfites.
Turkana Food Inc. issued a recall for 352 cases of the dried fruit Thursday through an announcement published on the Food and Drug Administration's (FDA) website.
Advertisement
The dried apricots have 200-gram paper packaging.
The move was precipitated by 'routine sampling performed by the New York State Department of Agriculture and Markets' that found the recalled dried apricots 'contained Sulfites that were not listed on the product labelling,' the FDA recall notice said.
Companies often use sulfites as a preservative in food and drinks, but some people can have allergic reactions to them.
The dried apricots lacking the declaration about sulfites have expiration date of November 2026.
Advertisement
They also have the lot number '440090478-15-333' and the UPC label '2539560010,' according to the recall notice.
Shoppers who bought Floria Dried Apricots with that particular lot number 'should not consume the product,' the recall notice said.
Turkana Food Inc. recalled 352 cases of the dried fruit.
zigres – stock.adobe.com
Instead, they should return the product to the store where it was purchased for a refund.
Advertisement
There haven't been any reported illnesses from the undeclared sulfites.
According to the FDA, Turkana Food distributed the recalled dried apricots in the following states:
Florida
Kentucky
Virginia
New York
New Jersey
Tennessee
Massachusetts
Texas
Illinois
Indiana
Michigan
Rhode Island
Pennsylvania
North Carolina
Maryland
Ohio
Alabama
Missouri
California
The company and the FDA are investigating to 'correct the issue with the manufacturer,' according to the FDA notice.
Advertisement
In the meantime, it has stopped producing and distributing them.
The FDA issued the recall in 19 states including New York, New Jersey and Pennsylvania.
REUTERS
Turkana Food, headquartered in New Jersey, describes itself as a 'family-owned and operated ethnic food distributor.'
It serves independent supermarkets, chain stores and institutions, according to its website.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Post
12 hours ago
- New York Post
Popular dried fruit pulled from shelves in 19 states
A recall of certain cases of Floria Dried Apricots is underway due to their packaging not disclosing the fruit contains sulfites. Turkana Food Inc. issued a recall for 352 cases of the dried fruit Thursday through an announcement published on the Food and Drug Administration's (FDA) website. Advertisement The dried apricots have 200-gram paper packaging. The move was precipitated by 'routine sampling performed by the New York State Department of Agriculture and Markets' that found the recalled dried apricots 'contained Sulfites that were not listed on the product labelling,' the FDA recall notice said. Companies often use sulfites as a preservative in food and drinks, but some people can have allergic reactions to them. The dried apricots lacking the declaration about sulfites have expiration date of November 2026. Advertisement They also have the lot number '440090478-15-333' and the UPC label '2539560010,' according to the recall notice. Shoppers who bought Floria Dried Apricots with that particular lot number 'should not consume the product,' the recall notice said. Turkana Food Inc. recalled 352 cases of the dried fruit. zigres – Instead, they should return the product to the store where it was purchased for a refund. Advertisement There haven't been any reported illnesses from the undeclared sulfites. According to the FDA, Turkana Food distributed the recalled dried apricots in the following states: Florida Kentucky Virginia New York New Jersey Tennessee Massachusetts Texas Illinois Indiana Michigan Rhode Island Pennsylvania North Carolina Maryland Ohio Alabama Missouri California The company and the FDA are investigating to 'correct the issue with the manufacturer,' according to the FDA notice. Advertisement In the meantime, it has stopped producing and distributing them. The FDA issued the recall in 19 states including New York, New Jersey and Pennsylvania. REUTERS Turkana Food, headquartered in New Jersey, describes itself as a 'family-owned and operated ethnic food distributor.' It serves independent supermarkets, chain stores and institutions, according to its website.


Time Business News
12 hours ago
- Time Business News
How to Stay Compliant Amid Amazon's Growing Focus on Allergen Labeling
Selling on Amazon used to be about standing out. Now it's equally about staying compliant. As regulations tighten across global markets, Amazon is placing greater emphasis on product safety, and allergen labeling has moved to the front of the line. Undeclared allergens can trigger life-threatening reactions for consumers. This is why Amazon now demands clear, verified allergen disclosures across many product categories, from supplements and skincare to packaged foods. Sellers who overlook these rules risk listing delays, account suspensions, or far more serious legal trouble. Here, we break down Amazon's evolving allergen compliance requirements, the products affected, which allergens must be disclosed, and how sellers can meet Amazon's demands before risking costly disruptions. Allergen compliance on Amazon is no longer optional or negotiable. The platform's increasing focus reflects broader regulatory and public health concerns worldwide. Food allergies are rising globally. For sensitive individuals, even trace exposure to allergens can cause severe reactions. Regulatory agencies expect retailers—online or brick-and-mortar—to ensure proper disclosures that protect consumers. Amazon's allergen rules are designed to reduce these safety risks. Amazon operates internationally and must comply with laws set by agencies like the FDA (U.S.), EFSA (EU), Health Canada, and others. As these regulators increase enforcement on allergen mislabeling, Amazon proactively adjusts its own compliance policies to stay aligned. When undeclared allergens trigger safety incidents, both the seller and Amazon may face regulatory investigations or lawsuits. Strengthening allergen compliance helps Amazon reduce legal exposure while preserving consumer trust. Allergen labeling requirements don't apply to every category equally. Amazon's policies focus on high-risk product groups that pose ingestion or dermal contact risks. Supplements often contain ingredients derived from major allergens like soy, shellfish, dairy, or nuts. Amazon requires sellers to fully disclose all potential allergens both on the product label and within Amazon's listing backend. While applied externally, many skincare products contain ingredients that may trigger allergic skin reactions. Formulations using nut oils, wheat proteins, soy extracts, or egg derivatives may fall under allergen disclosure policies. Amazon's food and grocery listings demand full allergen labeling in line with regional food safety laws. This includes both intentional ingredients and possible cross-contamination risks during manufacturing. Amazon's allergen requirements reflect regional regulations that differ by country. Sellers listing products across multiple Amazon marketplaces must comply with each market's allergen lists. In the United States, Amazon sellers must disclose the following major allergens: Milk Eggs Fish Crustacean shellfish Tree nuts Peanuts Wheat Soybeans Sesame (officially added in 2023) European regulations expand this list further. In the EU and UK, sellers must disclose 14 allergens, which include: Gluten-containing grains (wheat, barley, rye, oats) Lupin Celery Mustard Sulfites (above specific thresholds) Mollusks (alongside crustaceans) Other markets have unique allergen lists. For example, Canada includes sesame, mustard, and sulfites under its priority allergen list, while Japan has its own set of required disclosures. Sellers must verify requirements for each Amazon marketplace they serve. Amazon enforces allergen compliance through both product documentation and its listing creation process. Product labels must include visible allergen declarations following each market's regulatory format. In many regions, allergens must be bolded or listed in separate 'Contains' statements to ensure clarity for consumers. Amazon may require sellers to submit certificates of analysis (COAs), ingredient specifications, and supplier documentation verifying allergen content or absence. Some sellers may also need manufacturing allergen control plans if requested during compliance reviews. During listing creation, Amazon's product attribute forms often include mandatory allergen declaration fields. Sellers must complete these fields truthfully to ensure alignment between backend data and physical labeling. Inaccurate or incomplete allergen disclosures expose sellers to serious consequences, both within Amazon's platform and under local regulatory laws. Amazon may block new product listings or suspend existing ASINs if allergen data is missing, inconsistent, or conflicts with submitted documentation. Resubmissions can delay sales and impact seller metrics. Undeclared allergens that lead to consumer reactions may result in lawsuits, class actions, or FDA enforcement. Sellers remain legally responsible for the safety of their products, even when fulfilled through Amazon. Sellers who repeatedly violate allergen policies risk escalated audits, Amazon account reviews, or permanent bans from selling in certain markets. Working with accredited laboratories offers sellers defensible allergen verification that supports Amazon submissions and reduces compliance risk. Labs use methods like ELISA (enzyme-linked immunosorbent assay), PCR (polymerase chain reaction), or mass spectrometry to detect even trace levels of allergens. This ensures both intentional ingredients and potential cross-contamination risks are properly identified. Labs help manufacturers assess whether shared production equipment or supplier raw materials may introduce unintended allergens into finished products. Expert labs generate clear allergen testing reports, manufacturing allergen control statements, and supporting documents that align with Amazon's compliance documentation standards. Regulatory requirements shift frequently. Expert labs stay current and guide Amazon sellers through these changing allergen compliance landscapes. Labs help sellers align allergen disclosures across multiple Amazon marketplaces, ensuring that products remain compliant whether sold in the U.S., EU, Canada, or Australia. Labs assess supplier facilities to verify allergen control protocols, manufacturing segregation, and cleaning procedures that prevent accidental cross-contact. For sellers requiring periodic verification—especially those using shared production facilities—labs offer batch-by-batch testing programs to confirm ongoing allergen compliance before shipping inventory to Amazon warehouses. Allergen labeling is a high-stakes compliance issue that directly affects consumer safety, regulatory standing, and a seller's ability to maintain active listings. Accurate allergen disclosure backed by verified laboratory testing ensures sellers meet Amazon's growing compliance demands while protecting both their customers and their Qalitex to schedule allergen testing and secure fully documented compliance for your Amazon listings across all global marketplaces. TIME BUSINESS NEWS


Business Insider
16 hours ago
- Business Insider
UroGen Pharma price target raised to $16 from $3 at Goldman Sachs
Goldman Sachs analyst Paul Choi raised the firm's price target on UroGen Pharma (URGN) to $16 from $3 and keeps a Neutral rating on the shares following yesterday's approval of Zusduri. The firm cites the stock being bid up (+22% following FDA approval of Zusduri in patients with low-grade intermediate-risk non muscle-invasive bladder cancer, which was surprising to most investor expectations given the negative ODAC advisory committee briefing document and vote that the drug's overall benefit-risk profile was not favorable, the analyst tells investors in a research note. Although the FDA is not obligated to follow the ODAC's recommendation, approvals following negative advisory committee meeting votes, particularly in oncology, are exceedingly rare, the firm adds. Confident Investing Starts Here: